- li>
- li>
- li>
- li>
- li>
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 1.37 | 1.30 | 5.32 |
| EPS, GAAP | 1.39 | 1.38 | 1.38 |
| Consensus Estimate | 1.38 | 1.30 | 6.00 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 5.63 | 4.96 | 13.45 |
| EPS, GAAP | 5.62 | 5.49 | 2.37 |
| Consensus Estimate | 5.66 | 5.10 | 10.92 |
| BDX | Industry Average | |
| P/E (TTM) | 13.14 | NA |
| P/E (Forward) | 13.12 | NA |
| PEG Ratio | 1.61 | 1.15 |
| Price/Sales | 1.94 | 1.95 |
| Beta | 0.51 | 0.94 |
| 6:43 AM | 5/1/2012 | Becton Dickinson 2Q Net Down 6.7% On Increased Expenses; Raises Fiscal Year View |
| 5/7/2012 | Barron's 500 (Barrons.com) |
| 4/19/2012 | Illumina Could Remain In the Spotlight (WSJ.com) |
| 4/10/2012 | Corning to Boost Life-Sciences Business (WSJ.com) |
| 3/29/2012 | Roche Should Resist More Genetic Engineering (WSJ.com) |
| 2/28/2012 | Looking for "Quality Growth" Stocks (Barrons.com) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)